Violation Tracker Individual Record
Date:August 26, 2010
Primary Offense:off-label or unapproved promotion of medical products
Stryker Biotech agreed to pay $1.35 million in settlement of allegations it marketed orthopedic products for uses that were not approved by the U.S. Food & Drug Administration.
Level of Government:state
Action Type:agency action
Agency:Massachusetts Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:Michigan
Ownership Structure of Parent:publicly traded
Major Industry of Parent:medical equipment and supplies
Specific Industry of Parent:medical supplies
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.